SecBot SecBot
144 ·Filed Oct 30, 2026

LLY

ELI LILLY & Co
NEUTRAL
Impact 3/10
Horizondays Processed17d 8h ago SEC0000316011-26-000040
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The endowment's consistent selling pattern suggests ongoing portfolio rebalancing rather than a negative view on Lilly. Monitor future Form 144 and Form 4 filings for any acceleration in selling pace, which could signal a change in the endowment's long-term holding strategy.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$1,417.54
T+0 close · Oct 30, 2026 · via day close
Latest settled
−4.48%
T+5 · $1,354.00 · next T+20 in 13d
Vs SPY
−1.78%
α at T+5
Latest observation
+1.33%
T+9 · FF3 residual α
  1. T+0 · Oct 30 $1,417.54entry
  2. T+1 · 15d ago −0.46%α +0.02% · $1,410.99
  3. T+5 · 11d ago −4.48%α −1.78% · $1,354.00
  4. T+11 · todayOpen
  5. T+20 · in 13d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Lilly Endowment Inc., the company's largest shareholder with a $108.4B stake, filed a Form 144 notice of intent to sell 295,000 shares of Eli Lilly common stock, valued at approximately $405 million based on the filing date. The endowment has been actively selling shares in recent months, with prior sales totaling over $1.1 billion since August 2026. This is a routine portfolio rebalancing by a long-term charitable holder, not an insider trading signal.

Key Facts

  • Lilly Endowment Inc. intends to sell 295,000 shares of Eli Lilly common stock.
  • Estimated value of the proposed sale is $405,241,500 based on the filing.
  • The endowment has sold approximately 1,007,403 shares in four separate transactions since August 2026, totaling over $1.1 billion.
  • Lilly Endowment is the largest institutional holder with a $108.4B stake as of Q2 2026.
  • The sale represents about 0.37% of the endowment's total holdings, a small fraction.

Financial Impact

Proposed sale of 295,000 shares valued at ~$405 million, representing ~0.03% of LLY's $1.21 trillion market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur or may be at different terms.
  • Continued large-scale selling by the endowment could create modest downward pressure on the stock.
  • No material change in company fundamentals is indicated by this filing.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0000316011-26-000040
Document: 0000316011-26-000040-index.html0000316011-26-000040
Document: 0000316011-26-000040.txt0000316011-26-000040

Track record

23 reports on LLY

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +31.53% at T+60 after the Apr 16, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Oct 30, 202617d ago 144 Neutral 3/10 Viewing Entry $1,417.54 to $1,410.99 Now $1,431.67 +1.00% ▼ −0.46% +0.02% vs SPY
  2. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $1,373.70 to $1,417.54 Now $1,431.67 +4.22% ▲ +3.19% +4.96% vs SPY
  3. Oct 26, 202621d ago Press Release Neutral 2/10 Entry $1,279.14 to $1,281.91 Now $1,431.67 +11.92% ▲ +0.22% −0.34% vs SPY
  4. Oct 26, 202622d ago Court Ruling Neutral 3/10 Entry $1,281.91 to $1,288.30 Now $1,431.67 +11.68% ▲ +0.50% +0.15% vs SPY
  5. Oct 19, 202628d ago SC 13G/A Neutral 3/10 Entry $1,240.34 to $1,283.66 Now $1,431.67 +15.43% ▲ +3.49% +3.16% vs SPY
  6. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $1,240.34 to $1,283.66 Now $1,431.67 +15.43% ▲ +3.49% +3.16% vs SPY
  7. Oct 15, 20264w ago Press Release Neutral 1/10 Entry $1,251.61 to $1,257.03 Now $1,431.67 +14.39% ▲ +0.43% +1.54% vs SPY
  8. Oct 7, 20265w ago 144 Neutral 3/10 Entry $1,188.72 to $1,169.60 Now $1,431.67 +20.44% ▼ −1.61% −1.19% vs SPY
  9. Sep 11, 20269w ago Press Release Bullish 5/10 Entry $1,115.70 to $1,138.28 Now $1,431.67 +28.32% ▲ +2.02% +2.47% vs SPY
  10. Sep 8, 202610w ago Court Ruling Neutral 4/10 Entry $1,124.21 to $1,123.00 Now $1,431.67 +27.35% ▼ −0.11% +0.49% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (11h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026